EP Patent
EP3652148B1 — Amorphous form of vilanterol trifenatate and processes for the preparation thereof
Assigned to Hovione Scientia Ltd · Expires 2021-08-25 · 5y expired
What this patent protects
Patent listed against Ohtuvayre.
Drugs covered by this patent
- Ohtuvayre (ENSIFENTRINE) · Verona Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.